Arcturus Therapeutics Holdings (ARCT) Debt to Equity (2018 - 2025)
Historic Debt to Equity for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Q1 2025 value amounting to $0.06.
- Arcturus Therapeutics Holdings' Debt to Equity changed N/A to $0.06 in Q1 2025 from the same period last year, while for Mar 2025 it was $0.06, marking a year-over-year change of. This contributed to the annual value of $0.22 for FY2022, which is 1885.53% down from last year.
- According to the latest figures from Q1 2025, Arcturus Therapeutics Holdings' Debt to Equity is $0.06.
- In the past 5 years, Arcturus Therapeutics Holdings' Debt to Equity ranged from a high of $0.41 in Q3 2022 and a low of $0.06 during Q1 2025
- Moreover, its 4-year median value for Debt to Equity was $0.23 (2022), whereas its average is $0.24.
- Per our database at Business Quant, Arcturus Therapeutics Holdings' Debt to Equity surged by 62645.56% in 2021 and then plummeted by 8258.71% in 2023.
- Arcturus Therapeutics Holdings' Debt to Equity (Quarter) stood at $0.28 in 2021, then fell by 18.86% to $0.22 in 2022, then tumbled by 68.17% to $0.07 in 2023, then fell by 10.14% to $0.06 in 2025.
- Its Debt to Equity was $0.06 in Q1 2025, compared to $0.07 in Q3 2023 and $0.22 in Q4 2022.